LHC Share Price Performance
R12.38
-2.81 (-18.50%)
9.6% undervalued intrinsic discount
R13.70
Fair Value
Price R12.38
AnalystHighTarget R13.70
AnalystConsensusTarget R12.86
AnalystLowTarget R12.30
Fair ValueR13.70
Share Pricen/a
Life Healthcare Group Holdings Limited Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 19 Fair Values set on narratives written by author
LHC Community Narratives
AN
Fair Value
·Fair Value R13.7 9.6% undervalued intrinsic discount
Aging Population And Digital Health Will Redefine Healthcare
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
Fair Value
·Fair Value R12.86 3.7% undervalued intrinsic discount
Expanding NeuraCeq Sales And Southern Africa Hospitals Will Improve Future Market Position
0users have liked this narrative
0users have commented on this narrative
15users have followed this narrative
AN
Fair Value
·Fair Value R12.3 0.7% overvalued intrinsic discount
Rising Regulatory Burdens And Costs Will Shrink South African Demand
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
Expanding NeuraCeq Sales And Southern Africa Hospitals Will Improve Future Market Position
Key Takeaways Expansion in Southern Africa and investments in high-margin imaging services are expected to significantly boost revenue and future earnings. An under-leveraged balance sheet positions the company well to fund growth opportunities, enhancing return on equity.Read more
AN
R12.86
3.7% undervalued intrinsic discount
Fair Value
Profit Margin
9.71%
Future PE
9.9x
Price in 2029
R20.22
Aging Population And Digital Health Will Redefine Healthcare
Key Takeaways Accelerating hospital expansion and digital health investments are set to drive sustained growth and open new high-margin revenue streams. Strong balance sheet and efficient capital management enable aggressive geographic expansion and high returns compared to competitors.Read more
AN
R13.7
9.6% undervalued intrinsic discount
Fair Value
Profit Margin
14.01%
Future PE
6.78x
Price in 2029
R21.54
Rising Regulatory Burdens And Costs Will Shrink South African Demand
Key Takeaways Long-term revenue growth is threatened by shifts to outpatient care, rising labor costs, and regulatory pressures constraining pricing power and margins. Structural economic and affordability barriers, along with high fixed costs, may limit patient volumes and dampen returns on investment.Read more
AN
R12.3
0.7% overvalued intrinsic discount
Fair Value
Profit Margin
10.12%
Future PE
9.68x
Price in 2028
R19.59
Trending Discussion
Recently Updated Narratives
AN
LHC: Stable Assumptions And Growing Minority Stakes Will Shape Future Returns
Fair Value: R12.86 3.7% undervalued intrinsic discount
15 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
LHC: JPMorgan Upgrade And Earnings Resilience Will Shape Future Share Performance
Fair Value: R13.7 9.6% undervalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Rising Regulatory Burdens And Costs Will Shrink South African Demand
Fair Value: R12.3 0.7% overvalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Life Healthcare Group Holdings Limited Key Details
Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
May 28, 2026
- -1.07
- 27.79%
- -6.04%
- 26.9%
About LHC
- Founded
- 1983
- Employees
- n/a
- CEO
- WebsiteView website
Life Healthcare Group Holdings Limited, an investment holding company, operates as a private healthcare company in Southern Africa. It operates through Southern Africa – Hospitals Services, Southern Africa - Complementary Services, Southern Africa - Healthcare Services, and International segments. The company operates acute hospitals; and Life Nkanyisa care centres that provide long-term chronic mental healthcare, frail care rehabilitation, step-down care, correctional services, primary healthcare, and substance abuse recovery programme services to patients in the public sector. It also offers mental health, acute rehabilitation, renal dialysis, oncology, and diagnostics services; and training for pharmacists, pharmacists’ assistants, and nurses. In addition, the company provides nursing and pharmacy services; and health and well-being, occupational health, emergency medical, and complementary and advisory services. Further, it retains the right to manufacture, commercialise, and distribute Life Molecular Imaging (LMI) products, such as early-stage novel radiotherapeutic and radio diagnostic products in Africa. The company was formerly known as Afrox Healthcare Limited and changed its name to Life Healthcare Group Holdings Limited in January 2005. Life Healthcare Group Holdings Limited was founded in 1983 and is headquartered in Johannesburg, South Africa.
Recent LHC News & Updates
LHC: JPMorgan Upgrade And Margin Improvements Will Support Future Upside
Analysts have modestly lifted their price target for Life Healthcare Group Holdings to ZAR13.70. This reflects updated assumptions for slightly higher revenue growth, firmer profit margins and a marginally lower future P/E, as highlighted in recent Street research.